

Request Sample Report
The Open Surgery Heart Valves market is experiencing steady growth, driven by increasing cardiac surgeries and technological advancements. The market size is projected to reach approximately $5 billion by 2026, reflecting a compound annual growth rate of around 6%. Key factors include rising prevalence of heart diseases and demand for innovative valve solutions.
◍ Abbott Vascular Inc.
◍ Arterius Ltd
◍ Cardionovum GmbH
◍ Aneuclose LLC
◍ InspireMD, Inc
◍ Tepha, Inc.
◍ Boston Scientific Corporation
◍ Japan Stent Technology Co., Ltd.
◍ Gaudi Vascular, Inc.
◍ MicroVention, Inc.
The Open Surgery Heart Valves Market features key players like Abbott Vascular, Boston Scientific, and others. These companies enhance market growth through innovative valve technologies and surgical solutions. Their commitment to R&D and expanding product portfolios drives market expansion. Revenue figures vary, with Abbott reporting approximately $10 billion in 2022.
Request Sample Report
Hospital
Clinic
Others
Request Sample Report
Mechanical Valves
TAVR Valves
Request Sample Report
$ X Billion USD